GE Healthcare launches new program to simplify AI development, implementation

GE Healthcare has launched a new program designed to make it easier for health systems to implement AI solutions. The Edison Developer Program, named after the company’s Edison AI platform, gives users immediate access to a variety of algorithms and applications intended to improve patient care.

GE Healthcare has also released a variety of new Edison solutions. These include the Edison Open AI Orchestrator, which helps customers integrate clinical applications into their PACS workflow, and a new AI-powered CT scanner intended to “simplify, streamline and automate the entire CT experience.”

“We introduced Edison just one year ago at RSNA to help health providers take advantage of data in new and significant ways,” Kieran Murphy, president and CEO of GE Healthcare, said in a prepared statement. “With the introduction of the Edison Developer Program, and a suite of new intelligent applications and smart devices powered by Edison, we are building on that promise as we continue to work with partners to realize our collective goal of advancing the future of health.”

In the statement, GE Healthcare also highlighted its collaborations with companies such as Arterys, iCAD, Koios Medical, MaxQ AI and Volpara, noting that those working relationships were crucial in the development of its newest Edison-based solutions.

“The opportunities for healthcare with a truly intelligent connected digital enterprise are significant, but no one organization can get there alone,” Amit Phadnis, GE Healthcare’s chief digital officer, said in the same statement. “The Edison Developer Program is unique in its deep technology integration and scaling through the workflow, opening the door to faster adoption by health systems. Bringing together leading technology providers, developers and academic institutions under a single, connected ecosystem will help our customers simplify and optimize data aggregation and orchestration of clinical and operational applications in ways that have the potential to create real impact from the bottom line to better patient outcomes.”